Acorah Software Products - Accounts Production 16.8.200 false true false true No description of principal activity 1 June 2024 31 March 2025 31 March 2025 07251114 Mr Kojo Amoako-Wiredu Mr Kwadwo Amoako-Wiredu Mr Kwadwo Amoako-Wiredu iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07251114 2024-05-31 07251114 2025-03-31 07251114 2024-06-01 2025-03-31 07251114 frs-core:CurrentFinancialInstruments 2025-03-31 07251114 frs-bus:PrivateLimitedCompanyLtd 2024-06-01 2025-03-31 07251114 frs-bus:FilletedAccounts 2024-06-01 2025-03-31 07251114 frs-bus:Micro-entities 2024-06-01 2025-03-31 07251114 frs-bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-03-31 07251114 frs-bus:Director1 2024-06-01 2025-03-31 07251114 frs-bus:Director2 2024-06-01 2025-03-31 07251114 frs-bus:CompanySecretary1 2024-06-01 2025-03-31
Registered number: 07251114
Kaizen Pharma Limited
Unaudited Financial Statements
For the Period 1 June 2024 to 31 March 2025
TaxAssist Accountants
476 St. Albans Road
Watford
WD24 6QU
Balance Sheet
Registered number: 07251114
31 March 2025
£
Current assets 4,330
Creditors: Amounts Falling Due Within One Year 30,512
NET CURRENT ASSETS 34,842
TOTAL ASSETS LESS CURRENT LIABILITIES 34,842
Accruals and deferred income (392 )
NET ASSETS 34,450
CAPITAL AND RESERVES 34,450

Notes

1. General Information
Kaizen Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07251114 . The registered office is Unit 9 11 Main Drive, East Lane, Wembley, HA9 7ND.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Kojo Amoako-Wiredu
Director
23/12/2025